Evidence map›Paper›PMID 37345519›Full record

ArticleStatistics in medicine2023

Group sequential testing under instrumented difference-in-differences approach.

Samrat Roy, Ting Ye, Ashkan Ertefaie, Tat-Thang Vo, James Flory, Sean Hennessy, Dylan Small

Abstract read
In one paragraph

Article in Statistics in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Samrat RoyDepartment of Statistics and Data Science, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-0436-0164
Ting YeDepartment of Biostatistics, University of Washington, Seattle, Washington, USA.
Ashkan ErtefaieDepartment of Biostatistics and Computational Biology, University of Rochester, Rochester, New York, USA.ORCID 0000-0003-2611-9512
Tat-Thang VoDepartment of Statistics and Data Science, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0001-6485-9947
James FloryDepartment of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Sean HennessyDivision of Epidemiology, DBEI, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Dylan SmallDepartment of Statistics and Data Science, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Funding

Enhancing the Utility of the Trend-in-Trend Research DesignR01AG064589 · NIA · UNIVERSITY OF PENNSYLVANIA · PI HENNESSY, SEAN, SMALL, DYLAN S · 2019 to 2022
$2.2M
NIA NIH HHS R01 AG064589
6 · The paper itself

Abstract

Unmeasured confounding is a major obstacle to reliable causal inference based on observational studies. Instrumented difference-in-differences (iDiD), a novel idea connecting instrumental variable and standard DiD, ameliorates the above issue by explicitly leveraging exogenous randomness in an exposure trend. In this article, we utilize the above idea of iDiD, and propose a novel group sequential testing method that provides valid inference even in the presence of unmeasured confounders. At each time point, we estimate the average or conditional average treatment effect under iDiD setting using the data accumulated up to that time point, and test the significance of the treatment effect. We derive the joint distribution of the test statistics under the null using the asymptotic properties of M-estimation, and the group sequential boundaries are obtained using the

Indexed as

BiasStatistics as TopicHumansLactonesMyocardial InfarctionSafety-Based Drug WithdrawalsSulfonesLactonesrofecoxibSulfonesgroup sequential testinginstrumented DiDM-estimationstandard DiDstandard IVunmeasured confounding

Identifiers

PMID37345519
PMCPMC13303180

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.